期刊文献+

膀胱移行细胞癌组织Notch-1和Jagged-1蛋白表达临床意义的探讨 被引量:4

Expressions and clinical significance of Notch-1 and Jagged-1 in bladder transitional cell carcinoma tissues
原文传递
导出
摘要 目的:探讨Notch-1及其配体Jagged-1在膀胱移行细胞癌组织中的表达及临床意义。方法:采用免疫组化SP法检测Notch-1和Jag-ged-1在52例膀胱移行细胞癌组织和10例正常膀胱组织中的表达,并结合临床资料进行分析。结果:52例膀胱癌组织中Notch-1和Jag-ged-1蛋白的阳性表达率分别为76.9%(40/52)和75.0%(39/52)。10例正常膀胱组织中Notch-1阳性表达率为40.0%(4/10),Jagged-1阳性表达率为50.0%(5/10)。随着膀胱癌病理分级和临床分期的增高,Notch-1和Jagged-1蛋白的阳性表达率均增高,P<0.05。复发组Notch-1和Jagged-1蛋白的阳性表达率均高于未复发组,差异有统计学意义,P<0.05。Notch-1和Jagged-1的表达强度之间呈明显正相关,r=0.316,χ2=5.200,P=0.013。结论:Notch-1及其配体Jagged-1可能是判断膀胱癌生物学行为的重要指标。 OBJECTIVE: To investigate the expressions of Notch-1 and Jaggedl in bladder transitional cell carcinoma tissues and their clinical significance. METHODS:The expressions of Notch-1 and Jagged-1 in 52 specimens of bladder transitional cell carcinoma and 10 specimens of normal bladder tissues were detected by SP of immunohistoehemistry. The results were analyzed in relation to the clinical data. RESULTS: The positive rates of Notch-1 and Jagged-1 in bladder carcinoma were 76.9% (40/52) and 75.0O/oo (39/52), respectively. The positive expression rates of Notch-1 and Jagged-1 were 40.0% (4/10) and 50.0% (5/10) respectively in the 10 nomal bladder tissues. The abnormal expressions of Notch-1 and Jagged-1 were related to the tumor grade, clinical stage and recurrence,P〈0.05. Meanwhile, the correlation between Notch-1 expression and Jagged-1 expression was statistically significant (r= 0. 316, χ^2 = 5. 200, P=0. 013). CONCLUSION: Notch 1 and Jagged-1 may be important prognostic indicators and potentially useful for assessing the biological behavior of bladder transitional cell carcinoma.
出处 《中华肿瘤防治杂志》 CAS 2009年第16期1242-1245,共4页 Chinese Journal of Cancer Prevention and Treatment
关键词 移行细胞/病理学 膀胱肿瘤/病理学 NOTCH-1 JAGGED-1 免疫组织化学 carcinoma,transitional cell/pathology bladder neoplasms/pathology Notch-1 Jagged-1 immunohistochemistry
  • 相关文献

参考文献15

  • 1Sanderson S, Salanti G, Higgins J. Joint effects of the Nacetyltransferase 1 and 2 (NAT1 and NAT2) genes and smoking on bladder carcinogenesis: a literature-based systematic HuGE review and evidence synthesis[J].Am J Epidemiol, 2007, 166(7):741- 751.
  • 2顾方六,刘玉立.50年泌尿男生殖系肿瘤发病和构成情况的变迁[J].中华泌尿外科杂志,2002,23(2):88-90. 被引量:138
  • 3Yoon K, Gaiano N. NOTCH signaling in the mammalian central nervous system: insights from mouse mutants[J]. Nat Neurosci, 2005, 8(6):709 -715.
  • 4Tonon G, ModiS, Wu L, et al. t(11;19) (q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a NOTCH signaling pathway[J]. Nat Genet, 2003, 33(2):208-213.
  • 5李宁忱.膀胱癌诊断治疗指南[M]//那彦群.中国泌尿外科疾病诊断治疗指南.北京:人民卫生出版社,2007:120-134.
  • 6Musaechio M,Perrimon N. The Drosophila kekkon genes: novel members of both the leucine-rich repeat and immunoglobulin superfamilies expressed in the CNS[J]. Dev Biol, 1996, 178(1): 63-76.
  • 7Artavanis Tsakonas S, Rand M D, Lake R J. NOTCH signaling: cell fate control and signal integration in development[J]. Science, 1999, 284(5415) :770-776.
  • 8Allman D, Aster J C, Pear W S. NOTCH signaling in hematopoiesis and early lymphocyte development [J]. Immunol Rev, 2002, 187(1) :75-86.
  • 9Shimizu K, Chiba S, Kumano K, et al. Mouse JAGGED1 physically interacts with NOTCH2 and other NOTCH receptors[J]. J Biol Chem,1999, 274(46) :32961 -32969.
  • 10V arnum Finney B, Purton L E, Yu M, et al. The NOTCH lig and, JAGGED-1, influences the development of primitive hematopoietic precursor cells[J]. Blood, 1998, 91(11): 4084-4091.

二级参考文献1

  • 1顾方六 吴阶平.泌尿及男性生殖系肿瘤发病和构成情况的变迁[J].中华外科杂志,1980,19:488-490.

共引文献141

同被引文献44

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1368
  • 2Ditte CA, $tine JP, Louise HJ, et al. Characterization of dlkl + cell emerging during skeletal muscle remodeling in response to myositis,myopathies and acute injury[J]. Stem Cell Express, 2009,8(1) :12 19.
  • 3Benetatos L, Hatzimichael E, Londin E, et al. The microRNAs within the DLK1 DIO3 genomic region: involvement in disease pathogenesis[J]. Cell Mol Life Sci, 2013,70(5) : 795-814.
  • 4Baladrona V, Ruiz-Hidalgo MJ, Nueda ML, et al. dlk acts as a negative regulator of Notch1 activation through interactions with specific EGF like repeats[J]. Experimental Cell Research, 2005 303 (6) : 343-359.
  • 5Urs S,Turner B,Tang Y, et al. Effect of soluble Jaggedl-media- ted inhibition of Notch signaling on proliferation and differentia- tion of an adipocyte progenitor cell model[J]. Adipocyte, 2012,1 (1) z46 57.
  • 6Harukin, Kawaguchi KS, Eichenberger S, et al. Dominant-negative Notch3 receptor inhibits mitogen-activated protein Kinase pathway and the growth of human lung cancer.Cancer res,2005,65(9):3555-3661.
  • 7Zhiwei W, Yiwei L.Sanjeev B,et al. Exploitation of the Notch Signaling Pathway as a Novel Target for Cancer Therapy.Anticancer Research, 2008,28: 3621-3630.
  • 8Iso T,Kedes L,Hamamori Y.HES and HERP famihes:multiple effectors of the Notch signaling pathwayJ Cell Physiol,2003,194(3):237-255.
  • 9Fu YJ,Ye F,Lv WG,et al.Recent researches on the Notch signaling pathway.Med Mol Biol,2007,4(5):447-450.
  • 10Greenwald I, Kovall R. Notch signaling: genetics and structure. Worm Book, 2013,17:1-28.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部